Patent Assignment
Reel/Frame 061656/0894
Assignment of Assignor's Interest
Recorded: 2022-11-04
Pages: 11
Assignors
AMYLIN PHARMACEUTICALS, LLC
Executed: 2015-01-09
ASTRAZENECA PHARMACEUTICALS LP
Executed: 2015-01-09
Assignee
AEGERION PHARMACEUTICALS, INC.
ONE MAIN STREET, SUITE 800, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Engineered Polypeptides Having Enhanced Duration of Action
Application:
18/049,445 →
Publication:
US 2023/0115655
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2022
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 063250/0649 →
Assignment of Assignor's Interest
Nov 4, 2022
From: ERICKSON, MARY; LITZINGER, DAVID D.; GHOSH, SOUMITRA S.; GUO, ZIJIAN
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 061657/0123 →
Change of Name
Nov 4, 2022
From: AEGERION PHARMACEUTICALS, INC.
To: AMRYT PHARMACEUTICALS INC.
Reel/Frame 061882/0992 →
Change of Name
Nov 4, 2022
From: AMYLIN PHARMACEUTICALS, INC.
To: AMYLIN PHARMACEUTICALS, LLC
Reel/Frame 061883/0017 →